Long non‑coding RNA ZEB1‑AS1 indicates poor prognosis and promotes melanoma progression through targeting miR‑1224‑5p

Wang,Qiong; Zhang,Ruirui; Liu,Dandan

doi:10.3892/etm.2018.7005

Long non‑coding RNA ZEB1‑AS1 indicates poor prognosis and promotes melanoma progression through targeting miR‑1224‑5p

Authors:
- Qiong Wang
- Ruirui Zhang
- Dandan Liu
View Affiliations

Affiliations: Department of Plastic and Aesthetic Surgery, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei 441021, P.R. China
Published online on: November 23, 2018 https://doi.org/10.3892/etm.2018.7005
Pages: 857-862

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Long non‑coding RNAs (lncRNAs) have critical roles in various types of cancer, but their roles in the development of melanoma and the underlying molecular mechanisms remain to be fully elucidated. In the present study, the role of zinc finger E‑box binding homeobox 1 antisense RNA 1 (ZEB1‑AS1) in melanoma was assessed. The expression levels of ZEB1‑AS1 were increased in melanoma cell lines and tumor tissues as indicated by reverse transcription‑quantitative polymerase chain reaction analysis. Kaplan‑Meier analysis suggested that higher expression of ZEB1‑AS1 predicts poor prognosis of melanoma patients. Furthermore, knockdown of ZEB1‑AS1 inhibited the proliferation, migration and invasion of melanoma, suggesting a role of ZEB1‑AS1 in the development and progression of melanoma. In addition, a luciferase reporter assay confirmed that the expression of miR‑1224‑5p was directly regulated by ZEB1‑AS1. Transfection with miR‑1224‑5p mimics reduced the levels of ZEB1‑AS1 and the proliferation, migration and invasion of melanoma. In conclusion, ZEB1‑AS1 enhances the proliferation, migration and invasion of melanoma, at least in part by inhibiting the expression of miR‑1224‑5p, and its overexpression is associated with poor survival of melanoma patients. In addition, the ZEB1‑AS1/miR‑1224‑5p interaction may be a promising therapeutic target for melanoma treatment.

View Figures

View References

1	Levin DB, Wilson K, Valadares de Amorim G, Webber J, Kenny P and Kusser W: Detection of p53 mutations in benign and dysplastic nevi. Cancer Res. 55:4278–4282. 1995.PubMed/NCBI
2	Wallack MK, Sivanandham M, Balch CM, Urist MM, Bland KI, Murray D, Robinson WA, Flaherty LE, Richards JM, Bartolucci AA, et al: A phase III randomized, doúble-blind, multiinstitutional trial of vaccinia melanoma oncolysate-active specific immunotherapy for patients with stage II melanoma. Cancer. 75:34–42. 2015. View Article : Google Scholar
3	Busam KJ, Berwick M, Blessing K, Fandrey K, Kang S, Karaoli T, Fine J, Cochran AJ, White WL, Rivers J, et al: Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol. 147:1049–1056. 1995.PubMed/NCBI
4	Surhone LM, Tennoe MT and Henssonow SF: Treatment and prognosis of melanoma. Betascript Publishing. 2010.
5	Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB and Maddox WA: A multifactorial analysis of melanoma: Prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg. 188:732–742. 1978. View Article : Google Scholar : PubMed/NCBI
6	Yarmishyn AA and Kurochkin IV: Long noncoding RNAs: A potential novel class of cancer biomarkers. Front Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
7	Schmidt K, Joyce CE, Buquicchio F, Brown A, Ritz J, Distel RJ, Yoon CH and Novina CD: The lncRNA SLNCR1 mediates melanoma invasion through a conserved SRA1-like Region. Cell Rep. 15:2025–2037. 2016. View Article : Google Scholar : PubMed/NCBI
8	Wei Y, Sun Q, Zhao L, Wu J, Chen X, Wang Y, Zang W and Zhao G: LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma. Med Oncol. 33:882016. View Article : Google Scholar : PubMed/NCBI
9	Yong S, Cheng H, Wang G, Yu G, Zhang D, Wang Y, Fan W and Yang W: Deregulation of miR-183 promotes melanoma development via lncRNA MALAT1 regulation and ITGB1 signal activation. Oncotarget. 8:3509–3518. 2017.PubMed/NCBI
10	Liu C and Lin J: Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1. Am J Transl Res. 8:4095–4105. 2016.PubMed/NCBI
11	Lv QL, Hu L, Chen SH, Sun B, Fu ML, Qin CZ, Qu Q, Wang GH, He CJ and Zhou HH: A long noncoding RNA ZEB1-AS1 promotes tumorigenesis and predicts poor prognosis in Glioma. Int J Mol Sci. 17(pii): E14312016. View Article : Google Scholar : PubMed/NCBI
12	Su W, Xu M, Chen X, Chen N, Gong J, Nie L, Li L, Li X, Zhang M and Zhou Q: Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer. Mol Cancer. 16:1422017. View Article : Google Scholar : PubMed/NCBI
13	Li L, Wang QF, Zou ML, He XA and Lv JJ: Overexpressed lncRNA ZEB1-AS1 promotes cell invasion and angiogenesis through Wnt/β-catenin signaling in non-small cell lung cancer. Int J Clin Exp Patho. 10:3990–3997. 2017.
14	Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z, Deng X, Chen H, Shen B, Peng C, et al: Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene. 35:1575–1584. 2016. View Article : Google Scholar : PubMed/NCBI
15	Liu B, Ye B, Yang L, Zhu X, Huang G, Zhu P, Du Y, Wu J, Qin X, Chen R, et al: Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression. Nat Immunol. 18:499–508. 2017. View Article : Google Scholar : PubMed/NCBI
16	Dalby B, Cates S, Harris A, Ohki EC, Tilkins ML, Price PJ and Ciccarone VC: Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods. 33:95–103. 2004. View Article : Google Scholar : PubMed/NCBI
17	Wang J, Dong Y, Wang X, Ma H, Sheng Z, Li G, Lu G, Sugimura H and Zhou X: Expression of EphA1 in gastric carcinomas is associated with metastasis and survival. Oncol Rep. 24:1577–1584. 2010.PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Xiao B, Zhu ED, Li N, Lu DS, Li W, Li BS, Zhao YL, Mao XH, Guo G, Yu PW and Zou QM: Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol Rep. 27:559–566. 2012.PubMed/NCBI
20	Li J, Li Z, Leng K, Xu Y, Ji D, Huang L, Cui Y and Jiang X: ZEB1-AS1: A crucial cancer-related long non-coding RNA. Cell Prolif. 51:2018.doi: 10.1111/cpr.12423. View Article : Google Scholar
21	Lin J, Zhan Y, Liu Y, Chen Z, Liang J, Li W, He A, Zhou L, Mei H, Wang F and Huang W: Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer. Oncotarget. 8:24202–24212. 2017.PubMed/NCBI
22	Liu XJ, Li SL, Li JS, Lu H, Yin LL, Zheng WF and Wang WC: Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis. Eur Rev Med Pharmacol Sci. 22:2624–2630. 2018.PubMed/NCBI
23	Liu C, Pan C, Cai Y and Wang H: Interplay between long noncoding RNA ZEB1-AS1 and miR-200s regulates osteosarcoma cell proliferation and migration. J Cell Biochem. 118:2250–2260. 2017. View Article : Google Scholar : PubMed/NCBI
24	Zhang LL, Zhang LF, Guo XH, Zhang DZ, Yang F and Fan YY: Downregulation of miR-335-5p by long noncoding RNA ZEB1-AS1 in gastric cancer promotes tumor proliferation and invasion. DNA Cell Biol. 37:46–52. 2018. View Article : Google Scholar : PubMed/NCBI
25	Wei N, Wei H and Zhang H: Long non-coding RNA ZEB1-AS1 promotes glioma cell proliferation, migration and invasion through regulating miR-577. Eur Rev Med Pharmacol Sci. 22:3085–3093. 2018.PubMed/NCBI
26	Jin Q, Rui L, Wang YY, Shi Y, Luan WK, Tao T, Zhang JX, Xu YC and You YP: MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas. Mol Cell Biochem. 403:33–41. 2015. View Article : Google Scholar : PubMed/NCBI
27	Qian J, Li R, Wang YY, Luan WK, Tao T, Zhang JX, Xu YC and You YP: MiR-1224-5p acts as a tumor suppressor by targeting CREB1 in malignant gliomas. Mol Cell Biochem. 403:33–41. 2015. View Article : Google Scholar : PubMed/NCBI
28	Yao X, Cui X, Wu X, Xu P, Zhu W, Chen X and Zhao T: Tumor suppressive role of miR-1224-5p in keloid proliferation, apoptosis and invasion via the TGF-β1/Smad3 signaling pathway. Biochem Biophys Res Commun. 495:713–720. 2018. View Article : Google Scholar : PubMed/NCBI